Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery of bioactive microbial gene products in inflammatory bowel disease

25 May 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Probiotics and Fermented Foods

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35614211
DOI: 10.1038/s41586-022-04648-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Discovery of bioactive microbial gene products in inflammatory bowel diseasePMID 35614211Read ↗

Microbial genes and pathways in inflammatory bowel diseaseSemantic proximity Read ↗

Finding inflammatory bowel disease genes will lead to a cure.Semantic proximity Read ↗

Microbial pathogenesis in inflammatory bowel diseasesSemantic proximity Read ↗

Genes, microbes, and T cells--new therapeutic targets in Crohn's disease.Semantic proximity Read ↗

Gene–environment interactions shape the host–microbial interface in inflammatory bowel diseaseSemantic proximity Read ↗

Microbial factors in inflammatory bowel diseaseSemantic proximity Read ↗

New therapeutic strategies for treatment of inflammatory bowel diseaseSemantic proximity Read ↗

Microbial Influences in Inflammatory Bowel DiseasesSemantic proximity Read ↗

Genetically engineered bacteria as inflammatory bowel disease therapeuticsSemantic proximity Read ↗

From probiotic chassis to modification strategies, control and improvement of genetically engineered probiotics for inflammatory bowel diseaseSemantic proximity Read ↗

IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.